Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 2;3(7):1010-1012.
doi: 10.1016/j.jaccas.2021.03.025. eCollection 2021 Jul 7.

A Case for Re-Gifting

Amanda C Coniglio  1 , Richa Agarwal  1 , Jacob N Schroder  2 , Robert J Mentz  1   3 , Carmelo A Milano  2 , Adam D DeVore  1   3 , Chetan B Patel  1
Affiliations
Case Reports

A Case for Re-Gifting

Amanda C Coniglio et al. JACC Case Rep. .

Abstract

Many patients die while waiting for a heart transplant. Therefore, it is vital that all suitable organs are used for transplantation. We present a case of an allograft that was transplanted twice and outline considerations regarding tissue typing, the impact of repeated ischemic time, and ethical considerations with allograft retransplantation. (Level of Difficulty: Intermediate.).

Keywords: HLA, human leukocyte antigen; HT, heart transplantation; MFI, mean fluorescence intensity; cardiac transplant; imaging; systolic heart failure.

PubMed Disclaimer

Conflict of interest statement

Dr. Mentz has received research support and honoraria from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Medtronic, Merck, Novartis, Roche, Sanofi, and Vifor. Dr. DeVore has received research support from the American Heart Association, Amgen, AstraZeneca, Bayer, Intra-Cellular Therapies, American Regent, Inc, the National Heart, Lung and Blood Institute, Novartis, and the Patient-Centered Outcomes Research Institute; and also provides consulting services for Amgen, AstraZeneca, Bayer, CareDx, InnaMed, LivaNova, Mardil Medical, Novartis, Procyrion, scPharmaceuticals, Story Health, and Zoll. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Late Gadolinium Hyperenhancement of the Mid–Left Ventricular Inferior Wall Representing Approximately 1% of the Overall Myocardial Mass
See this image and copyright information in PMC

References

    1. Nemec P., Bedanova H., Ostrizek T. Successful re-use of the transplanted heart. Ann Thorac Surg. 2010;90:1337–1338. - PubMed
    1. Meiser B.M., Uberfuhr P., Reichenspurner H. One heart transplanted successfully twice. J Heart Lung Transplant. 1994;13:339–340. - PubMed
    1. Simsir S.A., Fontana G.P., Czer L.S., Schwarz E.R. Heart allograft transplanted twice. Eur J Cardiothorac Surg. 2008;34:918–919. - PubMed
    1. Planinc M., Mihaljevic T., Jarrett C.M. One heart in 3 patients. Ann Thorac Surg. 2012;94:e143–e144. - PubMed
    1. Mullen J.C., Kuurstra E.J., Burhani M.S. Successful recycling of a previously transplanted heart: another option for limited resources. Can J Cardiol. 2014;30:1460.e1–1460.e2. - PubMed

Publication types